Matias Chiarastelli Salomao

Dr. Matias Chiarastelli Salomao


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Brazilian Journal of Medical and Biological Research
Verified
Journal Article
Open access
PDF file
RSReinaldo Salomao
Reinaldo Salomao
BFBianca L. Ferreira
Bianca L. Ferreira
MSMatias Chiarastelli Salomao
Matias Chiarastelli Salomao
SSS.S. Santos
S.S. Santos
LAL.C.P. Azevedo
L.C.P. Azevedo
MBMilena Karina Coló Brunialti
Milena Karina Coló Brunialti
Sepsis remains a major cause of morbidity and mortality worldwide, with increased burden in low- and middle-resource settings. The role of the inflammatory response in the pathogenesis of the syndrome has supported the modern concept of sepsis. Nevertheless, a definition of sepsis and the criteria for its recognition is a continuous process, which reflects the growing knowledge of its mechanisms and the success and failure of diagnostic and therapeutic interventions. Here we review the evolving concepts of sepsis, from the “systemic inflammatory response syndrome triggered by infection” (Sepsis-1) to “a severe, potentially fatal, organic dysfunction caused by an inadequate or dysregulated host response to infection” (Sepsis-3). We focused in the pathophysiology behind the concept and the criteria for recognition and diagnosis of sepsis. A major challenge in evaluating the host response in sepsis is to characterize what is protective and what is harmful, and we discuss that, at least in part, the apparent dysregulated host response may be an effort to adapt to a hostile environment. The new criteria for recognition and diagnosis of sepsis were derived from robust databases, restricted, however, to developed countries. Since then, the criteria have been supported in different clinical settings and in different economic and epidemiological contexts, but still raise discussion regarding their use for the identification versus the prognostication of the septic patient. Clinicians should not be restricted to definition criteria when evaluating patients with infection and should wisely use the broad array of information obtained by rigorous clinical observation.

1 November 2017 in Journal of Hospital Infection
Verified
Journal Article
Closed access
MSMatias Chiarastelli Salomao
Matias Chiarastelli Salomao
TGT. Guimarães
T. Guimarães
DDD.F. Duailibi
D.F. Duailibi
MPM.B.M. Perondi
M.B.M. Perondi
LLL.S.H. Letaif
L.S.H. Letaif
ÍBÍcaro Boszczowski
Ícaro Boszczowski

1 June 2020 in Emerging Infectious Diseases
Verified
Journal Article
Open access
MSMatias Chiarastelli Salomao
Matias Chiarastelli Salomao
MFMaristela Pinheiro Freire
Maristela Pinheiro Freire
IBIcaro Boszczowski
Icaro Boszczowski
SRSueli F. Raymundo
Sueli F. Raymundo
AGAna Rubia Guedes
Ana Rubia Guedes
ALAnna S. Levin
Anna S. Levin
Carbapenem-Resistant Enterobacteriaceae in ICUs

1 January 2019 in Revista do Instituto de Medicina Tropical de São Paulo
Verified
Journal Article
Open access
PDF file
ÍBÍcaro Boszczowski
Ícaro Boszczowski
MSMatias Chiarastelli Salomao
Matias Chiarastelli Salomao
MMMaria Luísa Moura
Maria Luísa Moura
MFMaristela Pinheiro Freire
Maristela Pinheiro Freire
TGThais Guimarães
Thais Guimarães
SCSilvia Figueiredo Costa
Silvia Figueiredo Costa
Increased resistance to polymyxin in Klebsiella pneumoniae (ColRKP) has been observed. Molecular epidemiology, as well as the clinical impact of these difficult to treat pathogens need to be better characterized. We present the clinical outcomes of 28 patients infected by ColRKP in a tertiary hospital. Isolates with MIC >2 by Vitek 2 were confirmed by the microdilution broth test. Polymerase chain reaction (PCR) was performed for blaKPC, blaNDM, blaOXA-48 and blamcr-1 genes in the isolates, and Whole Genome Sequencing (WGS) was performed in six isolates. Seventeen (61%) patients were female and the mean age was 50 years old. In-hospital and 30-day mortality were 64% (18/28) and 53% (15/28), respectively. Central line-associated bloodstream infection in addition to bacteremia episodes due to other sources were the most frequent (61%). Mean APACHE and Charlson comorbidity index were 16 and 5, respectively. Twenty patients (71%) received at least one active drug and ten (35%) received two drugs: tigecycline 46% (13/28); amikacin 21% (6/28) and fosfomycin 3% (1 case). Twenty-six out of 28 tested cases were positive for blaKPC. Eight different clusters were identified. Four STs were detected (ST11, ST23, ST340, and ST437). Mutations on pmrA, arnB, udg, and yciM genes were present in all six isolates submitted to WGS; lpxMand mgrB mutations were also detected in all but one isolate. In conclusion, we observed resistance to polymyxin in severely ill patients mostly from intensive care units and/or immunosuppressed patients with high mortality rates in whom a diversity of ColRKP clusters was identified and might indicate selective pressure.

2 March 2022 in Frontiers in Medicine
Verified
Journal Article
Open access
JAJulio Alencar
Julio Alencar
LGLuz Marina Gómez Gómez
Luz Marina Gómez Gómez
ACAndre Lazzeri Cortez
Andre Lazzeri Cortez
HSHeraldo Possolo de Souza
Heraldo Possolo de Souza
ALAnna Sara Levin
Anna Sara Levin
MSMatias Chiarastelli Salomao
Matias Chiarastelli Salomao
SARS-CoV-2 infection has a wide spectrum of presentations, from asymptomatic to pneumonia and sepsis. Risk scores have been used as triggers for protocols that combine several interventions for early management of sepsis. This study tested the accuracy of the score SIRS, qSOFA, and NEWS in predicting outcomes, including mortality and bacterial infection, in patients admitted to the emergency department (ED) during the COVID-19 pandemic. We described 2,473 cases of COVID-19 admitted to the ED of the largest referral hospital for severe COVID-19 in Brazil during the pandemic. SIRS, qSOFA and NEWS scores showed a poor performance as prognostic scores. However, NEWS score had a high sensitivity to predict in-hospital death (0.851), early bacterial infection (0.851), and ICU admission (0.868), suggesting that it may be a good screening tool for severe cases of COVID-19, despite its low specificity.

7 May 2022 in Travel Medicine and Infectious Disease
Verified
Journal Article
Closed access
ANAna Catharina Nastri
Ana Catharina Nastri
ADAmaro Duarte-Neto
Amaro Duarte-Neto
LCLuciana Vilas Boas Casadio
Luciana Vilas Boas Casadio
William SouzaWilliam Souza
William Souza
ICIngra M. Claro
Ingra M. Claro
ALAnna S. Levin
Anna S. Levin